Renal Artery Thrombosis: A Post COVID-19 Sequel

Shrikant B Deshmukh; Kavita M Upadhyay; Advait Kulkarni; Sudhir Deshpande; Rajshri Purohit; Milind Kulkarni

Shrikant B Deshmukh M.D. (Medicine), DNB Nephrology, Consultant Department of Nephrology, Dr. Hedgewar Hospital, Aurangabad, Maharashtra, India.
Kavita M Upadhyay M.B.B.S., Resident DNB General Medicine, Dr. Hedgewar Hospital, Aurangabad, Maharashtra, India. https://orcid.org/0000-0002-7111-6671
Advait Kulkarni M.B.B.S., Resident DNB General Medicine, Dr. Hedgewar Hospital, Aurangabad, Maharashtra, India.
Sudhir Deshpande M.B.B.S, D.A, Intensivist, Dr. Hedgewar Hospital, Aurangabad, Maharashtra, India.
Rajshri Purohit M.S. (General Surgery), Dr. Hedgewar Hospital, Aurangabad, Maharashtra, India.
Milind Kulkarni M.B.B.S, D.A, Intensivist, Dr. Hedgewar Hospital, Aurangabad, Maharashtra, India.

Keywords: COVID-19, IgG SARS CoV-2, Renal Artery Thrombosis

Abstract

Since the outbreak of the COVID-19 pandemic, increasing evidence suggests that infected patients present a high incidence of thrombotic complications. Besides affecting respiratory tract it also causes systemic inflammation which also leads to coagulopathy affecting major blood vessels in the body. This report describes a case of aortic, renal artery thrombosis in a patient admitted for evaluation of abdominal pain and detected to have high titer of SARS COV-2 IgG antibodies with no prior history suggestive of typical COVID-19 infection (COVID-19 RTPCR and antigen tested negative).

How to cite this article:
Deshmukh SB, Upadhyay KM, Kulkarni A, Deshpande S, Purohit R, Kulkarni M. Renal Artery Thrombosis: A Post COVID-19 Sequel. J Adv Res Med 2020; 7(2): 22-24.

DOI: https://doi.org/10.24321/2349.7181.202009

References

Llitjos JF, Leclerc M, Chochois C, Monsallier JM, Ramakers M, Auvray M et al. High incidence of venous

thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost 2020.

Fabre O, Rebet O, Carjaliu I, Radutoiu M, Gautier L, Hysi I. Severe Acute Proximal Pulmonary Embolism and

COVID-19: A Word of Caution. Ann Thorac Surg 2020.

Zhang T, Sun LX, Feng RE. [Comparison of clinical and pathological features between severe acute respiratory

syndrome and coronavirus disease 2019]. Zhonghua Jie He He Hu Xi Za Zhi. 2020.

Chauhan AJ, Wiffen LJ, Brown TP. COVID-19: A collision of complement, coagulation and inflammatory pathways. Journal of Thrombosis and Haemostasis 2020.

Onkarappa Mangala Y, Daid SS, Lakshmanan S, Kapil R, Miskovsky J. Acute Pulmonary Embolism in COVID-19:

A Report of Two Cases. Cureus 2020.

Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM et al. Incidence of

thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020.

CDC. Symptoms of Coronavirus (COVID-19). Cdc 2020.

Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E et al. COVID-19 and Thrombotic or

Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC Stateof-

the-Art Review. Journal of the American College of Cardiology 2020.

Spiezia L, Boscolo A, Poletto F, Cerruti L, Tiberio I, Campello E et al. COVID-19-Related Severe

Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure. Thromb

Haemost 2020.

Barrett CD, Moore HB, Yaffe MB, Moore EE. ISTH interim guidance on recognition and management

of coagulopathy in COVID-19: A comment. Journal of Thrombosis and Haemostasis 2020.

AK, KGK, ED, GP, GSS, KS et al. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol 2020.

Zhai Z, Li C, Chen Y, Gerotziafas G, Zhang Z, Wan J et al. Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines. Thrombosis and Haemostasis 2020.

Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS et al. Endothelial cell

infection and endotheliitis in COVID-19. The Lancet 2020.